References
- Abey A, Johansson A, Schuiteneer B, Blum D. Methylergometrine poisoning in children: review of 34 cases. J Toxicol Clin Toxicol 2003; 41:249–253.
- Bangh S, Hughes K, Roberts D, Kovarik S. Neonatoal ergot poisoning: a persistent iatrogenic illness. Am J Perinatol 2005; 22:239–243.
- Dargaville P, Campbell N. Overdose of ergometrine in the newborn infant: acute symptomatology and long-term outcome. J Paediatr Child Health 1998; 34:83–89.
- Edwards W. accidental poisoning of newborn infants with ergonovine maleate; A lesson applicable to all delivery rooms. Clin Pediatr 1972; 10:257–260.
- Baum C, Hilpert P, Bhutani V. Accidental administration of an ergot alkaloid to a neonate. Pediatrics 1996; 98:457–458.
- Donatini B, Le Blaye I, Krupp P. Inadvertent administration of uterotonics to neonates. Lancet 1993; 341:839–840.
- Whitfield M, Salfield S. Accidental administration of syntometrine in adult dosage to the newborn. Arch Dis Child 1980; 55:68–70.
- Wells K, Zajko A, Webster M. Recognition and treatment of arterial insufficiency from cafergot. J Vasc Surg 1986; 4:abstract.
- Brunton L, Lazo J, Parker K. Goodman and Gilman's the Pharmacological Basis of Therapeutics. New York: McGraw-Hill Professional; 2006:309–310.
- Baselt R. Disposition of Toxic Drugs and Chemicals in Man. Seal Beach, CA: Biomedical Pubilcations; 2001:1002.
- Kosar E, Sumova A, Jakoubek B. Ergot Alkaloids Inhibit 3 H-Naloxone Binding to Opiate Receptors in the Rat Striatum and Hippocampus. Physiol Bohemoslov 1986; 35:334–339.
- Kattwinkel J, ed. The Textbook of Neonatal Resuscitation. 4th ed .The AHA/AAP Neonatal Resuscitation Program Steering Committee. Elk Grove Village, IL: American Heart Association; 2000.